HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 25-JUL-11 3T42 TITLE HUMAN ALDOSE REDUCTASE IN COMPLEX WITH A NITRILE-CONTAINING IDD TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDOSE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AR, ALDEHYDE REDUCTASE, ALDO-KETO REDUCTASE FAMILY 1 MEMBER COMPND 5 B1; COMPND 6 EC: 1.1.1.21; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKR1B1, ALDR1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TIM BARREL, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.XU,A.E.COHEN,S.G.BOXER REVDAT 2 13-SEP-23 3T42 1 REMARK SEQADV REVDAT 1 05-OCT-11 3T42 0 JRNL AUTH L.XU,A.E.COHEN,S.G.BOXER JRNL TITL ELECTROSTATIC FIELDS NEAR THE ACTIVE SITE OF HUMAN ALDOSE JRNL TITL 2 REDUCTASE: 2. NEW INHIBITORS AND COMPLICATIONS CAUSED BY JRNL TITL 3 HYDROGEN BONDS. JRNL REF BIOCHEMISTRY V. 50 8311 2011 JRNL REFN ISSN 0006-2960 JRNL PMID 21859105 JRNL DOI 10.1021/BI200930F REMARK 2 REMARK 2 RESOLUTION. 1.28 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6_289) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.28 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.29 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.130 REMARK 3 COMPLETENESS FOR RANGE (%) : 88.4 REMARK 3 NUMBER OF REFLECTIONS : 69094 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.152 REMARK 3 R VALUE (WORKING SET) : 0.151 REMARK 3 FREE R VALUE : 0.178 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.690 REMARK 3 FREE R VALUE TEST SET COUNT : 1860 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 22.2884 - 3.0058 0.97 5664 158 0.1357 0.1345 REMARK 3 2 3.0058 - 2.3867 0.98 5742 160 0.1417 0.1828 REMARK 3 3 2.3867 - 2.0853 0.96 5614 156 0.1481 0.1702 REMARK 3 4 2.0853 - 1.8947 0.94 5479 152 0.1599 0.1932 REMARK 3 5 1.8947 - 1.7590 0.95 5570 156 0.1232 0.1731 REMARK 3 6 1.7590 - 1.6553 0.94 5469 151 0.1132 0.1714 REMARK 3 7 1.6553 - 1.5724 0.94 5479 152 0.1072 0.1631 REMARK 3 8 1.5724 - 1.5040 0.85 4948 144 0.1747 0.2183 REMARK 3 9 1.5040 - 1.4461 0.84 4906 134 0.1687 0.1957 REMARK 3 10 1.4461 - 1.3962 0.86 5039 144 0.1704 0.2221 REMARK 3 11 1.3962 - 1.3526 0.76 4455 121 0.2335 0.2927 REMARK 3 12 1.3526 - 1.3139 0.84 4904 126 0.1734 0.2005 REMARK 3 13 1.3139 - 1.2793 0.68 3965 106 0.2732 0.3094 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.37 REMARK 3 B_SOL : 41.38 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.160 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.550 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.14 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.77890 REMARK 3 B22 (A**2) : 3.19470 REMARK 3 B33 (A**2) : -2.41570 REMARK 3 B12 (A**2) : 1.56850 REMARK 3 B13 (A**2) : 0.48890 REMARK 3 B23 (A**2) : -0.71560 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2772 REMARK 3 ANGLE : 1.341 3802 REMARK 3 CHIRALITY : 0.077 422 REMARK 3 PLANARITY : 0.006 483 REMARK 3 DIHEDRAL : 19.401 1056 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3T42 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-AUG-11. REMARK 100 THE DEPOSITION ID IS D_1000067010. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 4.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 73538 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.280 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.28 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.33 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.30100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2PZN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE HANGING DROP METHOD WAS USED TO REMARK 280 OBTAIN CRYSTALS (EASYXTAL TOOL 24 CULTURE PLATES, QIAGEN). WT REMARK 280 HALR2 WAS CO-CRYSTALLIZED WITH THE OXIDIZED FORM OF COENZYME REMARK 280 NADP+ (SIGMA) AND INHIBITOR 2 AT ROOM TEMPERATURE (RATIOS OF REMARK 280 PROTEIN / INHIBITOR / COENZYME = 1/2/2). HANGING DROPS WERE MADE REMARK 280 BY THE MIXING MOTHER LIQUOR (0.06 M CITRIC ACID, 0.04 M BIS-TRIS REMARK 280 PROPANE, 12% (W/V) PEG 3350, PH 4.2) WITH HOLOENZYME SOLUTION REMARK 280 (10 MG/ML, 20 MM HEPES, PH 7.0). CRYSTALS WERE OBSERVED AFTER REMARK 280 THREE DAYS OF EQUILIBRATION, EVAPORATION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 998 REMARK 465 SER A 999 REMARK 465 HIS A 1000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG1 THR A 243 OE2 GLU A 271 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 193 CD GLU A 193 OE2 -0.128 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU A 193 OE1 - CD - OE2 ANGL. DEV. = -13.2 DEGREES REMARK 500 GLU A 193 CG - CD - OE2 ANGL. DEV. = 13.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 316 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3T4 A 317 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A 318 DBREF 3T42 A 1001 315 UNP P15121 ALDR_HUMAN 1 316 SEQADV 3T42 GLY A 998 UNP P15121 EXPRESSION TAG SEQADV 3T42 SER A 999 UNP P15121 EXPRESSION TAG SEQADV 3T42 HIS A 1000 UNP P15121 EXPRESSION TAG SEQADV 3T42 ILE A 4 UNP P15121 LEU 5 CONFLICT SEQRES 1 A 319 GLY SER HIS MET ALA SER ARG ILE LEU LEU ASN ASN GLY SEQRES 2 A 319 ALA LYS MET PRO ILE LEU GLY LEU GLY THR TRP LYS SER SEQRES 3 A 319 PRO PRO GLY GLN VAL THR GLU ALA VAL LYS VAL ALA ILE SEQRES 4 A 319 ASP VAL GLY TYR ARG HIS ILE ASP CYS ALA HIS VAL TYR SEQRES 5 A 319 GLN ASN GLU ASN GLU VAL GLY VAL ALA ILE GLN GLU LYS SEQRES 6 A 319 LEU ARG GLU GLN VAL VAL LYS ARG GLU GLU LEU PHE ILE SEQRES 7 A 319 VAL SER LYS LEU TRP CYS THR TYR HIS GLU LYS GLY LEU SEQRES 8 A 319 VAL LYS GLY ALA CYS GLN LYS THR LEU SER ASP LEU LYS SEQRES 9 A 319 LEU ASP TYR LEU ASP LEU TYR LEU ILE HIS TRP PRO THR SEQRES 10 A 319 GLY PHE LYS PRO GLY LYS GLU PHE PHE PRO LEU ASP GLU SEQRES 11 A 319 SER GLY ASN VAL VAL PRO SER ASP THR ASN ILE LEU ASP SEQRES 12 A 319 THR TRP ALA ALA MET GLU GLU LEU VAL ASP GLU GLY LEU SEQRES 13 A 319 VAL LYS ALA ILE GLY ILE SER ASN PHE ASN HIS LEU GLN SEQRES 14 A 319 VAL GLU MET ILE LEU ASN LYS PRO GLY LEU LYS TYR LYS SEQRES 15 A 319 PRO ALA VAL ASN GLN ILE GLU CYS HIS PRO TYR LEU THR SEQRES 16 A 319 GLN GLU LYS LEU ILE GLN TYR CYS GLN SER LYS GLY ILE SEQRES 17 A 319 VAL VAL THR ALA TYR SER PRO LEU GLY SER PRO ASP ARG SEQRES 18 A 319 PRO TRP ALA LYS PRO GLU ASP PRO SER LEU LEU GLU ASP SEQRES 19 A 319 PRO ARG ILE LYS ALA ILE ALA ALA LYS HIS ASN LYS THR SEQRES 20 A 319 THR ALA GLN VAL LEU ILE ARG PHE PRO MET GLN ARG ASN SEQRES 21 A 319 LEU VAL VAL ILE PRO LYS SER VAL THR PRO GLU ARG ILE SEQRES 22 A 319 ALA GLU ASN PHE LYS VAL PHE ASP PHE GLU LEU SER SER SEQRES 23 A 319 GLN ASP MET THR THR LEU LEU SER TYR ASN ARG ASN TRP SEQRES 24 A 319 ARG VAL CYS ALA LEU LEU SER CYS THR SER HIS LYS ASP SEQRES 25 A 319 TYR PRO PHE HIS GLU GLU PHE HET NAP A 316 48 HET 3T4 A 317 27 HET CIT A 318 13 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM 3T4 {5-CHLORO-2-[(4-CYANO-3-NITROBENZYL) HETNAM 2 3T4 CARBAMOYL]PHENOXY}ACETIC ACID HETNAM CIT CITRIC ACID HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 2 NAP C21 H28 N7 O17 P3 FORMUL 3 3T4 C17 H12 CL N3 O6 FORMUL 4 CIT C6 H8 O7 FORMUL 5 HOH *431(H2 O) HELIX 1 1 PRO A 23 GLY A 38 1 16 HELIX 2 2 ALA A 45 GLN A 49 5 5 HELIX 3 3 ASN A 50 GLU A 64 1 15 HELIX 4 4 LYS A 68 LEU A 72 5 5 HELIX 5 5 TRP A 79 HIS A 83 5 5 HELIX 6 6 LEU A 87 LYS A 100 1 14 HELIX 7 7 ASN A 136 GLU A 150 1 15 HELIX 8 8 ASN A 162 ASN A 171 1 10 HELIX 9 9 GLN A 192 LYS A 202 1 11 HELIX 10 10 ASP A 230 HIS A 240 1 11 HELIX 11 11 THR A 243 GLN A 254 1 12 HELIX 12 12 THR A 265 LYS A 274 1 10 HELIX 13 13 SER A 281 SER A 290 1 10 HELIX 14 14 LEU A 300 THR A 304 5 5 SHEET 1 A 2 ARG A 3 LEU A 5 0 SHEET 2 A 2 LYS A 11 PRO A 13 -1 O MET A 12 N ILE A 4 SHEET 1 B 8 GLY A 16 GLY A 18 0 SHEET 2 B 8 HIS A 41 ASP A 43 1 O ASP A 43 N LEU A 17 SHEET 3 B 8 PHE A 73 LEU A 78 1 O VAL A 75 N ILE A 42 SHEET 4 B 8 LEU A 106 ILE A 109 1 O LEU A 108 N LEU A 78 SHEET 5 B 8 ILE A 156 SER A 159 1 O GLY A 157 N TYR A 107 SHEET 6 B 8 VAL A 181 GLU A 185 1 O VAL A 181 N ILE A 158 SHEET 7 B 8 VAL A 205 TYR A 209 1 O THR A 207 N ILE A 184 SHEET 8 B 8 VAL A 258 VAL A 259 1 O VAL A 258 N ALA A 208 SITE 1 AC1 38 GLY A 18 THR A 19 TRP A 20 LYS A 21 SITE 2 AC1 38 ASP A 43 TYR A 48 LYS A 77 HIS A 110 SITE 3 AC1 38 TRP A 111 SER A 159 ASN A 160 GLN A 183 SITE 4 AC1 38 TYR A 209 SER A 210 PRO A 211 LEU A 212 SITE 5 AC1 38 GLY A 213 SER A 214 PRO A 215 ASP A 216 SITE 6 AC1 38 LEU A 228 ALA A 245 ILE A 260 PRO A 261 SITE 7 AC1 38 LYS A 262 SER A 263 VAL A 264 THR A 265 SITE 8 AC1 38 ARG A 268 GLU A 271 ASN A 272 3T4 A 317 SITE 9 AC1 38 HOH A 371 HOH A 388 HOH A 389 HOH A 410 SITE 10 AC1 38 HOH A 459 HOH A 489 SITE 1 AC2 14 TRP A 20 VAL A 47 TYR A 48 HIS A 110 SITE 2 AC2 14 TRP A 111 THR A 113 PHE A 122 TRP A 219 SITE 3 AC2 14 ALA A 299 LEU A 300 CYS A 303 TYR A 309 SITE 4 AC2 14 NAP A 316 HOH A 482 SITE 1 AC3 9 GLN A 49 ASN A 50 GLU A 51 ASN A 52 SITE 2 AC3 9 GLU A 53 LYS A 94 ASP A 98 HOH A 344 SITE 3 AC3 9 HOH A 636 CRYST1 39.858 46.963 46.907 76.35 77.21 67.79 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025089 -0.010244 -0.004025 0.00000 SCALE2 0.000000 0.023000 -0.003937 0.00000 SCALE3 0.000000 0.000000 0.022179 0.00000